首页> 外国专利> ACUTE AND CHRONIC MITOCHONDRIAL ELECTRON TRANSPORT CHAIN DYSFUNCTION TREATMENTS AND GRAPHENIC MATERIALS FOR USE THEREOF

ACUTE AND CHRONIC MITOCHONDRIAL ELECTRON TRANSPORT CHAIN DYSFUNCTION TREATMENTS AND GRAPHENIC MATERIALS FOR USE THEREOF

机译:急性和慢性线粒体电子传输链功能障碍治疗及其使用的格拉芬材料

摘要

Modified hydrophilic carbon clusters (HCCs), poly(ethylene glycol)-hydrophilic carbon clusters (PEG-HCCs) and similarly structured materials like graphene quantum dots (GQDs), PEGylated GQDs, small molecule antioxidants, and PEGylated small molecule antioxidants. These materials have been modified with an iron chelating moiety, deferoxamine, or a similar chelating moiety. By exploiting common binding sites, the carbon nanostructure facilitates intracellular transport including in mitochondria, reduces oxidative breakdown of the chelator moiety prior to treatment, and reduces both the cause and consequences of metal induced oxidative stress within the body thus providing a novel form of therapy for a range of oxidative and metal-related toxicities. Graphenic materials can be used for the treatment of acute and chronic mitochondrial electron transport chain dysfunction.
机译:改性亲水碳簇(HCC),聚(乙二醇)-亲水碳簇(PEG-HCC)以及类似结构的材料,例如石墨烯量子点(GQD),PEG化GQD,小分子抗氧化剂和PEG化小分子抗氧化剂。这些材料已被铁螯合部分,去铁胺或类似的螯合部分改性。通过利用共同的结合位点,碳纳米结构促进了线粒体内的细胞内运输,在治疗前减少了螯合剂部分的氧化分解,并减少了金属在体内引起氧化应激的原因和后果,从而为癌症提供了一种新颖的治疗方法一系列的氧化和金属相关毒性。 Graphenic材料可用于治疗急性和慢性线粒体电子运输链功能障碍。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号